LGND Competitors & Alternatives
Compare Ligand Pharmaceuticals Incorporated with similar stocks in the same industry
Biotechnology
LGND
Main Stock$210.87
Tradestie Score
59
Market Cap
$3.49B
P/E Ratio
28.6
Revenue Growth
0.1%
Analyst Upside
+28.9%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ALKS
Alkermes Inc. plc
|
$37.53
|
$5.06B | 42.6 | 63 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$51.27
|
$4.94B | - | 55 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$71.21
|
$4.93B | - | 57 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$76.77
|
$4.84B | - | 58 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$102.03
|
$3.98B | - | 63 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$36.16
|
$3.92B | - | 58 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$82.00
|
$3.91B | - | 50 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$19.21
|
$3.83B | - | 51 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$19.55
|
$3.68B | - | 50 | Compare |
More LGND Analysis
Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry